Publicado por Jaya Publishing House, 2020
ISBN 10: 9389235103 ISBN 13: 9789389235104
Librería: Vedams eBooks (P) Ltd, New Delhi, India
EUR 26,62
Cantidad disponible: 5 disponibles
Añadir al carritoHardcover. Condición: New.
Idioma: Inglés
Publicado por VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2014
ISBN 10: 3659115266 ISBN 13: 9783659115264
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 80,85
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. pp. 104.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2023
ISBN 10: 6206179982 ISBN 13: 9786206179986
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 85,17
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2023
ISBN 10: 6206179982 ISBN 13: 9786206179986
Librería: moluna, Greven, Alemania
EUR 53,35
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659115266 ISBN 13: 9783659115264
Librería: preigu, Osnabrück, Alemania
EUR 47,85
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Drug-drug interactions of gemfibrozil and rosiglitazone-Indian study | Krishnan Karthickeyan (u. a.) | Taschenbuch | 104 S. | Englisch | 2014 | LAP LAMBERT Academic Publishing | EAN 9783659115264 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3848439816 ISBN 13: 9783848439812
Librería: Mispah books, Redhill, SURRE, Reino Unido
EUR 158,44
Cantidad disponible: 1 disponibles
Añadir al carritoPaperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Apr 2014, 2014
ISBN 10: 3659115266 ISBN 13: 9783659115264
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 54,90
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The study designed to investigate the effect of gemfibrozil on the pharmacokinetics of rosiglitazone in Indian healthy adult male volunteers. This prospective open label randomized two-way crossover study was conducted in 12 Indian healthy adult male volunteers after ethical committee approval. Rosiglitazone 4mg tablet was administered either with or without pre-treatment of gemfibrozil 600mg tablets twice daily for 3 days. Plasma drug concentrations from time 0 to 12 hours were estimated by validated HPLC-UV method. The pharmacokinetic parameters were calculated and compared for statistical significance and 95% confidence interval (CI). Gemfibrozil increased the bioavailability of rosiglitazone to the extent comparable with the reports found in literature. But the increased bioavailability of rosiglitazone even without interacting drug enhanced the risk of concentration dependent adverse effects of rosiglitazone in Indian subjects. This was further augmented by co-administration of gemfibrozil. These findings supported the regulator's recent decision to ban the drug in the country. 104 pp. Englisch.
Idioma: Inglés
Publicado por VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2014
ISBN 10: 3659115266 ISBN 13: 9783659115264
Librería: Majestic Books, Hounslow, Reino Unido
EUR 85,46
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand pp. 104 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3848439816 ISBN 13: 9783848439812
Librería: moluna, Greven, Alemania
EUR 41,67
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Chandra Shekar MottapallyChandra Shekar. M, Studied Master of Biotechnology at University of Madras and Pursuing Doctor of Philosophy at CAS in Marine Biology, Annamali University.,India.The microsatellites markers are highly .
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2023
ISBN 10: 6206179982 ISBN 13: 9786206179986
Librería: Majestic Books, Hounslow, Reino Unido
EUR 86,32
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659115266 ISBN 13: 9783659115264
Librería: moluna, Greven, Alemania
EUR 45,45
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Karthickeyan KrishnanKrishnan Karthickeyan, clinical pharmacist in JSS college of pharmacy, ooty and also pursuing PhD in pharmaceutical sciences. Completed master of pharmacy in pharmacy practice in 2008 with gold medal and bachelor.
Idioma: Inglés
Publicado por VDM Verlag Dr. Mueller Aktiengesellschaft & Co. KG, 2014
ISBN 10: 3659115266 ISBN 13: 9783659115264
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 87,26
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND pp. 104.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2023
ISBN 10: 6206179982 ISBN 13: 9786206179986
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 87,70
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing Apr 2014, 2014
ISBN 10: 3659115266 ISBN 13: 9783659115264
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 54,90
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -The study designed to investigate the effect of gemfibrozil on the pharmacokinetics of rosiglitazone in Indian healthy adult male volunteers. This prospective open label randomized two-way crossover study was conducted in 12 Indian healthy adult male volunteers after ethical committee approval. Rosiglitazone 4mg tablet was administered either with or without pre-treatment of gemfibrozil 600mg tablets twice daily for 3 days. Plasma drug concentrations from time 0 to 12 hours were estimated by validated HPLC-UV method. The pharmacokinetic parameters were calculated and compared for statistical significance and 95% confidence interval (CI). Gemfibrozil increased the bioavailability of rosiglitazone to the extent comparable with the reports found in literature. But the increased bioavailability of rosiglitazone even without interacting drug enhanced the risk of concentration dependent adverse effects of rosiglitazone in Indian subjects. This was further augmented by co-administration of gemfibrozil. These findings supported the regulator's recent decision to ban the drug in the country.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 104 pp. Englisch.
Idioma: Inglés
Publicado por LAP LAMBERT Academic Publishing, 2014
ISBN 10: 3659115266 ISBN 13: 9783659115264
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 54,90
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The study designed to investigate the effect of gemfibrozil on the pharmacokinetics of rosiglitazone in Indian healthy adult male volunteers. This prospective open label randomized two-way crossover study was conducted in 12 Indian healthy adult male volunteers after ethical committee approval. Rosiglitazone 4mg tablet was administered either with or without pre-treatment of gemfibrozil 600mg tablets twice daily for 3 days. Plasma drug concentrations from time 0 to 12 hours were estimated by validated HPLC-UV method. The pharmacokinetic parameters were calculated and compared for statistical significance and 95% confidence interval (CI). Gemfibrozil increased the bioavailability of rosiglitazone to the extent comparable with the reports found in literature. But the increased bioavailability of rosiglitazone even without interacting drug enhanced the risk of concentration dependent adverse effects of rosiglitazone in Indian subjects. This was further augmented by co-administration of gemfibrozil. These findings supported the regulator's recent decision to ban the drug in the country.